1). Archer GL., Mayhall CG. Comparison of epidemiologic markers used in investigation of an outbreak of methicillin resistant Staphylococcus aureus infections. J Clin Microbiol. 1983. 18:395–9.
2). Bouvet A., Fournier JM., Audurier A., Branger C., Orsoni A., Girard C. Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. J Clin Microbiol. 1990. 28:1338–41.
3). Daum RS., Ito T., Hiramatsu K., Hussain F., Mongkolrattanothai K., Jamklang M, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis. 2002. 186:1344–7.
4). Diep BA., Carleton HA., Chang RF., Sensabaugh GF., Perdreau Remington F. Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006. 193:1495–503.
5). Kilic A., Li H., Stratton CW., Tang YW. Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee. J Clin Microbiol. 2006. 44:4436–40.
6). Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961. 14:385–93.
Article
7). Cha EK., Chang KS., Hwang SM. Correlation between staphylococcal cassette chromosome mec type and coagulase serotype of methicillin-resistant Staphylococcus aureus. J Bacteriol Virol. 2009. 39:71–8.
8). Tomasz A., Nachman S., Leaf H. Stable classes of phenotypic expression in methicillin-resistamt clinical isolates of Staphylococci. Antimicrob Agents Chemother. 1991. 35:124–9.
9). Durand G., Bes M., Meugnier H., Enright MC., Forey F., Liassine N, et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol. 2006. 44:847–53.
10). Johnson WM., Tyler SD., Ewan EP., Ashton FE., Pollard DR., Rozee KR. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol. 1991. 29:426–30.
11). Kanemitsu K., Yamamoto H., Takemura H., Kaku M., Shimada J. Relatedness between the coagulase gene 3′-end region and coagulase serotypes among Staphylococcus aureus strains. Microbiol Immunol. 2001. 45:23–7.
12). Watanabe S., Ito T., Takeuchi F., Endo M., Okuno E., Hiramatsu K. Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J Bacteriol. 2005. 187:3698–707.
13). Hwang SM., Kim TU. Changes in coagulase serotype of Staphylococcus aureus isolates in Busan, 1994-2005. Korean J Microbiol. 2007. 43:346–50.
14). Lee M., Chong Y. Characteristics of methicillin-resistant Staphylococcus aureus isolated from wounds in Korean patients. J Infect Chemother. 1996. 2:130–5.
15). Lindsay JA., Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol. 2004. 12:378–85.
16). Lindsay JA., Moore CE., Day NP., Peacock SJ., Witney AA., Stabler RA, et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has unique combinations of surface associated and regulatory genes. J Bacteriol. 2006. 188:669–76.
17). Murray NE. Type I restriction systems. sophisticated molecular machines (a legacy of Bertani and Weigle). Microbiol Mol Biol Rev. 2000. 64:412–34.
Article
18). Waldron DE., Lindsay JA. Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol. 2006. 188:5578–85.
19). Périchon B., Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009. 53:4580–7.
20). DeLeo FR., Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009. 119:2464–74.